|
Market Closed -
NYSE
16:00:02 2026-11-20 EST
|
5-day change | 1st Jan Change | ||
| 161.03 USD | +3.00% |
|
-7.75% | +41.74% |
| 11-17 | DaVita Expands Availability Of Expanded Hemodialysis Therapy To Every U.S. Center | CI |
| 11-17 | DaVita Rolls Out Expanded Hemodialysis Therapy Across US Centers | MT |
Company Valuation: DaVita Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 11,592 | 6,728 | 9,570 | 12,263 | 8,021 | 10,132 | - | - |
| Change | - | -41.96% | 42.23% | 28.15% | -34.59% | 26.32% | - | - |
| Enterprise Value (EV) 1 | 19,945 | 15,313 | 17,497 | 20,779 | 17,689 | 20,845 | 20,865 | 20,972 |
| Change | - | -23.22% | 14.26% | 18.76% | -14.87% | 17.84% | 0.1% | 0.51% |
| P/E | 12.8x | 12.8x | 14.1x | 13.9x | 11.5x | 11.2x | 9.42x | 7.86x |
| PBR | 14.6x | 9.48x | 8.81x | 102x | -12x | -53.5x | -23x | -7.27x |
| PEG | - | -0.4x | 0.5x | 0.3x | -1.39x | 0.2x | 0.5x | 0.4x |
| Capitalization / Revenue | 1x | 0.58x | 0.79x | 0.96x | 0.59x | 0.71x | 0.69x | 0.66x |
| EV / Revenue | 1.72x | 1.32x | 1.44x | 1.62x | 1.3x | 1.46x | 1.41x | 1.36x |
| EV / EBITDA | 8.05x | 7.39x | 7.06x | 7.68x | 6.3x | 7.16x | 6.97x | 6.67x |
| EV / EBIT | 11.1x | 11.4x | 10.1x | 10.5x | 8.45x | 9.51x | 9.19x | 8.83x |
| EV / FCF | 15.5x | 18.7x | 11.7x | 14.2x | 13.5x | 23.7x | - | - |
| FCF Yield | 6.46% | 5.34% | 8.52% | 7.06% | 7.41% | 4.23% | - | - |
| Dividend per Share 2 | - | - | - | - | - | 5 | 2.5 | - |
| Rate of return | - | - | - | - | - | 3.11% | 1.55% | - |
| EPS 2 | 8.9 | 5.85 | 7.42 | 10.73 | 9.84 | 14.33 | 17.1 | 20.48 |
| Distribution rate | - | - | - | - | - | 34.9% | 14.6% | - |
| Net sales 1 | 11,619 | 11,610 | 12,140 | 12,816 | 13,643 | 14,240 | 14,761 | 15,403 |
| EBITDA 1 | 2,478 | 2,072 | 2,479 | 2,705 | 2,809 | 2,912 | 2,993 | 3,146 |
| EBIT 1 | 1,797 | 1,339 | 1,734 | 1,981 | 2,094 | 2,193 | 2,270 | 2,376 |
| Net income 1 | 978.4 | 560.4 | 691.5 | 936.3 | 746.8 | 937.4 | 1,014 | 1,076 |
| Net Debt 1 | 8,353 | 8,585 | 7,927 | 8,516 | 9,668 | 10,712 | 10,733 | 10,840 |
| Reference price 2 | 113.76 | 74.67 | 104.76 | 149.55 | 113.61 | 161.03 | 161.03 | 161.03 |
| Nbr of stocks (in thousands) | 101,900 | 90,104 | 91,348 | 82,000 | 70,600 | 62,921 | - | - |
| Announcement Date | 2/10/22 | 2/22/23 | 2/13/24 | 2/13/25 | 2/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 11.24x | 1.46x | 7.16x | 3.1% | 10.13B | ||
| 11.53x | 0.37x | 7.59x | 3.28% | 103B | ||
| 15.72x | 1.9x | 9.47x | 0.65% | 99.34B | ||
| -172.76x | 12.8x | -195.86x | -.--% | 39.62B | ||
| 16.05x | 1.66x | 10.02x | 2.31% | 31.77B | ||
| 27.01x | 2.36x | 13.39x | 0.79% | 29.81B | ||
| 25.02x | 2.76x | 14.03x | 1.28% | 28.42B | ||
| 7.24x | 1.43x | 6.24x | -.--% | 20.95B | ||
| 28.68x | 5.14x | 21.05x | 2.44% | 19.39B | ||
| 30.57x | 2.87x | 12.92x | 1.45% | 16.97B | ||
| Average | 0.03x | 3.28x | -9.40x | 1.53% | 40B | |
| Weighted average by Cap. | -1.81x | 2.82x | -10.22x | 1.6% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DVA Stock
- Valuation DaVita Inc.
Select your edition
All financial news and data tailored to specific country editions
















